CIK 0001175151
- Non-accelerated filer
- Smaller reporting company
Cytosorbents Corp
Sign in to watch- Ticker
- CTSO
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 980373793
- Phone
- +1 973-329-8885
- Business address
- 305 COLLEGE ROAD EAST, PRINCETON, NJ, 08540
- Former names
- MedaSorb Technologies CORP, GILDER ENTERPRISES INC
- Open-market buys, last 90 days
- $120,435
- in 4 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$120,435. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-02-24 | BARTLETT ROBERT HAWES Chief Medical Officer | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2017-01-30 | BARTLETT ROBERT HAWES Chief Medical Officer | Grant or award · Stock Option (right to buy) | +16,000 | 16,000 | ||
| 2016-06-07 | BARTLETT ROBERT HAWES Chief Medical Officer | Grant or award · Stock Option (right to buy) | +2,000 | 2,000 | ||
| 2016-06-07 | BARTLETT ROBERT HAWES Chief Medical Officer | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2015-04-08 | BARTLETT ROBERT HAWES Chief Medical Officer | Grant or award | +30,000 | 30,000 | ||
| 2015-04-08 | BARTLETT ROBERT HAWES Chief Medical Officer | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2010-05-05 | BARTLETT ROBERT HAWES Chief Medical Officer | Grant or award · Stock Option | +900,000 | 1,125,000 | ||
| 2010-01-04 | BARTLETT ROBERT HAWES Chief Medical Officer | Grant or award · Stock Option | +175,000 | 225,000 |
Page 1 of 1 · 8 trades